Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 54903 in Asthma Inadequately Controlled on SABA
NCT01458886Phase 2Withdrawn
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2011
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of olodaterol in asthma, sponsored by Boehringer Ingelheim. Planned start Nov 2011; status: withdrawn.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01458886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458886.